HOME >> BIOLOGY >> NEWS
Thin tough skin, slow-growing gills protect larval Antarctic fish

Very thin but hardy, unblemished skin and slow developing gills appear to be keys to survival for newly hatched Antarctic notothenioids, a group of fish whose adults thrive in icy waters because of antifreeze proteins (AFPs) in their blood.

Such adaptations are important, researchers at the University of Illinois at Urbana-Champaign say, because the larval fish of at least two species of notothenioids that inhabit the Ross Sea at McMurdo Sound and Terra Nova Bay surprisingly lack sufficient antifreeze to protect them through their first three months of life.

The unexpected discovery, reported online by the Journal of Experimental Biology ahead of regular publication, counters the assumption that these vital proteins must be present from the time of hatching -- a view held by scientists since fish AFPs were found in the 1960s.

Internal fluids such as blood in many notothenioids are about half as salty as seawater. While seawater reaches its freezing point at -1.91 degrees Celsius, fish fluids will freeze at about -1 degree Celsius. The water where these species dwell rarely rises above the freezing point and is regularly filled with ice crystals.

"The way that we've understood how adult polar fishes survive has been based on their use of these antifreeze proteins to lower the freezing point of their internal fluids," said lead author Paul A. Cziko, a research specialist in the department of animal biology. "We finally got a chance to look at the larval fish, and it seems that they don't always have to have antifreeze proteins to survive."

Cziko, who earned bachelor's degrees in honors biology and biochemistry in 2004 from Illinois, studied in Antarctica as an undergraduate with animal biology professors Chi-Hing (Christina) Cheng and Arthur L. DeVries, who discovered AFPs in notothenioids.

The research team, which also included Clive W. Evans of the University of Auckland in New Zealand, studied three notothenioid spe
'"/>

Contact: Jim Barlow, Life Sciences Editor
jebarlow@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
13-Feb-2006


Page: 1 2 3

Related biology news :

1. When the going gets tough, slime molds start synthesizing
2. Tyrannosaur survivorship -- tough times for teens
3. USC researchers find drug is tough tumor fighter
4. Siberian tigers hang tough
5. Now, self-healing materials can mimic human skin, healing again and again
6. Oral ZYVOX shows cost savings for outpatient treatment of skin, other infections vs. vancomycin
7. Human gland probably evolved from gills
8. Multinational research: protecting ecology means understanding people, too
9. No evidence that widely prescribed statins protect against prostate cancer
10. Rain forest protection works in Peru
11. New study suggests Concord grape juice may provide protection against breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Thin tough skin slow growing gills protect larval Antarctic fish

(Date:8/26/2015)... 26, 2015 The report "Multi-Factor Authentication ... Factor), Application (Travel & Immigration, Government, Banking, Defense, Commercial ... to 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is ... at a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual ... Solutions as number 1,361 in growth for the three years through 2014. Being named ... fastest-growing privately held organizations in the country. , “We are thrilled to make ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... recently presented new data on the relationship of genetics and hypertension at the ... on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
Cached News: